Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 10
Results: 13
Correction to: Fuzuloparib: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1203, doi. 10.1007/s40265-021-01551-9
- By:
- Publication type:
- Article
Loncastuximab Tesirine: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1229, doi. 10.1007/s40265-021-01550-w
- By:
- Publication type:
- Article
Correction to: Lazertinib: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Current Status of Clinical Trials on Tau Immunotherapies.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1135, doi. 10.1007/s40265-021-01546-6
- By:
- Publication type:
- Article
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1181, doi. 10.1007/s40265-021-01545-7
- By:
- Publication type:
- Article
Remimazolam: A Review in Procedural Sedation.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1193, doi. 10.1007/s40265-021-01544-8
- By:
- Publication type:
- Article
Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Fuzuloparib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1221, doi. 10.1007/s40265-021-01541-x
- By:
- Publication type:
- Article
Dostarlimab: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1213, doi. 10.1007/s40265-021-01539-5
- By:
- Publication type:
- Article
Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1171, doi. 10.1007/s40265-021-01532-y
- By:
- Publication type:
- Article
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.
- Published in:
- Drugs, 2021, v. 81, n. 10, p. 1153, doi. 10.1007/s40265-021-01530-0
- By:
- Publication type:
- Article